Mackenzie Ian R A
Department of Pathology, University of British Columbia and Vancouver General Hospital, British Columbia, Canada.
Alzheimer Dis Assoc Disord. 2007 Oct-Dec;21(4):S44-9. doi: 10.1097/WAD.0b013e31815c3486.
There is increasing recognition of a clinical overlap between frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). Recent advances in our understanding of the neuropathologic, biochemical, and genetic basis of these conditions provides evidence for a common underlying pathogenesis. The neuropathology in most cases of FTD with ALS is a subtype of frontotemporal lobar degeneration, characterized by neuronal inclusions that are immunoreactive for ubiquitin but not tau (frontotemporal lobar degeneration with ubiquitinated inclusions). These cases show significant pathologic overlap with clinically pure FTD and those with classic ALS. Moreover, the ubiquitinated pathologic protein in all these conditions has recently been identified as TDP-43. A number of families have been reported with autosomal dominant FTD-ALS linked to chromosome 9p and these also have TDP-43-positive frontotemporal lobar degeneration with ubiquitinated inclusions pathology. Together, these findings suggest that FTD-ALS is part of a clinicopathologic spectrum of disease, now identified as TDP-43 proteinopathies.
额颞叶痴呆(FTD)与肌萎缩侧索硬化症(ALS)之间存在临床重叠,这一认识正日益受到关注。近期我们对这些疾病的神经病理学、生物化学和遗传学基础的理解取得了进展,为共同的潜在发病机制提供了证据。大多数伴有ALS的FTD病例的神经病理学是额颞叶变性的一种亚型,其特征是神经元包涵体对泛素具有免疫反应性,但对tau蛋白无反应(伴有泛素化包涵体的额颞叶变性)。这些病例与临床单纯性FTD以及经典ALS病例存在显著的病理重叠。此外,最近已确定所有这些疾病中泛素化的病理性蛋白均为TDP-43。已报道了一些与9号染色体相关的常染色体显性遗传FTD-ALS家族,这些家族也存在TDP-43阳性且伴有泛素化包涵体病理的额颞叶变性。总之,这些发现表明FTD-ALS是疾病临床病理谱的一部分,目前被确定为TDP-43蛋白病。